NRx Accounts Payable vs Net Invested Capital Analysis

NRXPW Stock  USD 0.05  0  3.59%   
NRx Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating NRx Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NRx Pharmaceuticals is a good investment. Please check the relationship between NRx Pharmaceuticals Accounts Payable and its Net Invested Capital accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRx Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy NRx Stock please use our How to Invest in NRx Pharmaceuticals guide.

Accounts Payable vs Net Invested Capital

Accounts Payable vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NRx Pharmaceuticals Accounts Payable account and Net Invested Capital. At this time, the significance of the direction appears to have strong relationship.
The correlation between NRx Pharmaceuticals' Accounts Payable and Net Invested Capital is 0.75. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of NRx Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of NRx Pharmaceuticals' Accounts Payable and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of NRx Pharmaceuticals are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Accounts Payable i.e., NRx Pharmaceuticals' Accounts Payable and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

0.75
Relationship DirectionPositive 
Relationship StrengthSignificant

Accounts Payable

An accounting item on the balance sheet that represents NRx Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of NRx Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.
Most indicators from NRx Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NRx Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRx Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy NRx Stock please use our How to Invest in NRx Pharmaceuticals guide.Selling General Administrative is likely to climb to about 28.2 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 8.9 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses94.4M44.4M27.6M32.9M
Cost Of Revenue2K4K5K4.8K

NRx Pharmaceuticals fundamental ratios Correlations

-0.6-0.830.980.080.83-0.88-0.460.96-0.6-0.460.88-0.520.97-0.47-0.79-0.84-0.490.97-0.680.130.58-0.660.7-0.590.58
-0.60.59-0.620.02-0.090.340.0-0.5-0.050.0-0.270.23-0.51-0.030.050.610.01-0.530.00.360.06-0.050.06-0.060.06
-0.830.59-0.91-0.11-0.60.770.32-0.790.30.32-0.810.59-0.780.320.491.00.34-0.780.37-0.2-0.270.4-0.40.31-0.27
0.98-0.62-0.910.090.79-0.87-0.430.94-0.52-0.430.89-0.560.94-0.45-0.72-0.92-0.460.94-0.610.150.51-0.60.63-0.520.51
0.080.02-0.110.090.27-0.33-0.840.320.28-0.840.36-0.710.31-0.53-0.31-0.11-0.820.310.130.07-0.33-0.440.40.33-0.33
0.83-0.09-0.60.790.27-0.88-0.710.9-0.68-0.710.94-0.620.9-0.73-0.99-0.61-0.740.89-0.850.30.66-0.930.96-0.690.66
-0.880.340.77-0.87-0.33-0.880.61-0.910.530.61-0.920.58-0.910.490.830.760.64-0.90.58-0.4-0.470.83-0.80.65-0.47
-0.460.00.32-0.43-0.84-0.710.61-0.680.141.0-0.710.84-0.670.840.750.321.0-0.670.42-0.1-0.130.8-0.810.07-0.13
0.96-0.5-0.790.940.320.9-0.91-0.68-0.52-0.680.94-0.71.0-0.65-0.87-0.8-0.711.0-0.690.120.5-0.790.82-0.50.5
-0.6-0.050.3-0.520.28-0.680.530.14-0.520.14-0.55-0.05-0.520.170.670.290.16-0.510.7-0.47-0.870.55-0.620.87-0.87
-0.460.00.32-0.43-0.84-0.710.611.0-0.680.14-0.710.84-0.670.840.750.321.0-0.670.42-0.1-0.130.8-0.810.07-0.13
0.88-0.27-0.810.890.360.94-0.92-0.710.94-0.55-0.71-0.730.94-0.68-0.89-0.82-0.740.93-0.690.330.52-0.820.85-0.530.52
-0.520.230.59-0.56-0.71-0.620.580.84-0.7-0.050.84-0.73-0.680.870.60.60.86-0.680.40.160.10.64-0.61-0.10.1
0.97-0.51-0.780.940.310.9-0.91-0.671.0-0.52-0.670.94-0.68-0.64-0.87-0.79-0.71.0-0.690.110.5-0.780.81-0.510.5
-0.47-0.030.32-0.45-0.53-0.730.490.84-0.650.170.84-0.680.87-0.640.760.340.86-0.640.70.23-0.150.78-0.790.13-0.15
-0.790.050.49-0.72-0.31-0.990.830.75-0.870.670.75-0.890.6-0.870.760.50.78-0.860.86-0.26-0.670.94-0.990.66-0.67
-0.840.611.0-0.92-0.11-0.610.760.32-0.80.290.32-0.820.6-0.790.340.50.35-0.790.39-0.16-0.270.4-0.410.3-0.27
-0.490.010.34-0.46-0.82-0.740.641.0-0.710.161.0-0.740.86-0.70.860.780.35-0.70.46-0.09-0.150.82-0.830.1-0.15
0.97-0.53-0.780.940.310.89-0.9-0.671.0-0.51-0.670.93-0.681.0-0.64-0.86-0.79-0.7-0.680.10.49-0.780.81-0.50.49
-0.680.00.37-0.610.13-0.850.580.42-0.690.70.42-0.690.4-0.690.70.860.390.46-0.680.02-0.70.76-0.810.7-0.7
0.130.36-0.20.150.070.3-0.4-0.10.12-0.47-0.10.330.160.110.23-0.26-0.16-0.090.10.020.48-0.230.28-0.490.48
0.580.06-0.270.51-0.330.66-0.47-0.130.5-0.87-0.130.520.10.5-0.15-0.67-0.27-0.150.49-0.70.48-0.450.61-0.81.0
-0.66-0.050.4-0.6-0.44-0.930.830.8-0.790.550.8-0.820.64-0.780.780.940.40.82-0.780.76-0.23-0.45-0.960.62-0.45
0.70.06-0.40.630.40.96-0.8-0.810.82-0.62-0.810.85-0.610.81-0.79-0.99-0.41-0.830.81-0.810.280.61-0.96-0.620.61
-0.59-0.060.31-0.520.33-0.690.650.07-0.50.870.07-0.53-0.1-0.510.130.660.30.1-0.50.7-0.49-0.80.62-0.62-0.8
0.580.06-0.270.51-0.330.66-0.47-0.130.5-0.87-0.130.520.10.5-0.15-0.67-0.27-0.150.49-0.70.481.0-0.450.61-0.8
Click cells to compare fundamentals

NRx Pharmaceuticals Account Relationship Matchups

NRx Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets32.1M2.9M32.7M25.8M7.3M6.9M
Total Current Liabilities622.4K46.2M11.9M16.6M19.0M14.9M
Total Stockholder Equity29.5M(43.8M)20.8M7.4M(11.7M)(11.1M)
Net Debt2.0M(1.1M)(27.1M)(9.5M)4.6M4.8M
Retained Earnings369.5K(90.2M)(183.2M)(223.1M)(253.1M)(240.5M)
Accounts Payable622.4K3.2M3.7M2.1M4.6M2.3M
Cash6.01.9M27.6M20.1M4.6M8.6M
Non Current Assets Total32.0M11K15K21K431K409.5K
Non Currrent Assets Other1.011K15K21K431K452.6K
Cash And Short Term Investments6.01.9M27.6M20.1M4.6M8.6M
Common Stock Shares Outstanding508.8K34.3M46.9M65.8M7.6M7.2M
Liabilities And Stockholders Equity32.1M2.9M32.7M25.8M7.3M6.9M
Other Current Assets69.5K240K5.1M11.5M2.3M3.0M
Other Stockholder Equity29.1M46.4M204.0M230.3M241.3M253.4M
Total Liab2.6M46.7M11.9M18.4M19.0M15.7M
Total Current Assets69.5K2.9M32.7M25.8M6.9M10.8M
Common Stock24.5M43K59K67K84K79.8K
Short Long Term Debt Total2.0M797K518K10.5M9.2M9.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NRx Stock Analysis

When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.